The bacteria behind the sexually transmitted disease gonorrhea is known for developing antibiotic resistance. Now there are two new treatment options.

For the first time in nearly 40 years, the FDA approved a new antibiotic to treat gonorrhea, an STI that has grown increasingly resistant to existing therapies, emerging as a major global public ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet.

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a new study finds. This could put the medication, called gepotidacin, on track ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's Blujepa as an oral treatment for gonorrhea, a common sexually transmitted infection. The health regulator ...

Gonorrhea is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It primarily infects the ...

A new clinical study from investigators at the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) provides extremely promising data ...

treating gonorrhea with fluoroquinolone antibiotics such as Cipro, Floxin, and Levaquin. Instead, the CDC recommends only one class of drugs -- the cephalosporins, which are antibiotics such as ...

The only remaining oral antibiotic used for gonorrhea failed to cure the infection in nearly 7 percent of patients treated at a clinic in Toronto, Canadian researchers said on Monday in the first ...